You are here » Home » Companies » Company Overview » Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd.

BSE: 531633 Sector: Health care
NSE: LINCOLN ISIN Code: INE405C01035
BSE LIVE 15:43 | 05 Dec 192.85 -0.35
(-0.18%)
OPEN

190.75

HIGH

195.35

LOW

190.10

NSE LIVE 15:31 | 05 Dec 193.35 0.65
(0.34%)
OPEN

190.55

HIGH

194.90

LOW

190.00

OPEN 190.75
PREVIOUS CLOSE 193.20
VOLUME 5185
52-Week high 304.80
52-Week low 128.00
P/E 12.83
Mkt Cap.(Rs cr) 385.70
Buy Price 192.85
Buy Qty 3.00
Sell Price 0.00
Sell Qty 0.00
OPEN 190.75
CLOSE 193.20
VOLUME 5185
52-Week high 304.80
52-Week low 128.00
P/E 12.83
Mkt Cap.(Rs cr) 385.70
Buy Price 192.85
Buy Qty 3.00
Sell Price 0.00
Sell Qty 0.00

About Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a partnership firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a public limited company in Jan. '95. All the assets and business of the erstwhile partnership was transferred to the company. The company was carrying on its business by getting its products manufactur...> More

Lincoln Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   386
EPS - TTM () [*C] 15.03
P/E Ratio (X) [*C] 12.83
Face Value ()   10
Latest Dividend (%)   10.00
Latest Dividend Date 23 Sep 2016
Dividend Yield (%) 0.42
Book Value / Share () [*C] 91.86
P/B Ratio () [*C] 2.10
[*C] Consolidated     [*S] Standalone

Lincoln Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 77.66 95.36 -18.56
Other Income -
Total Income 77.66 95.36 -18.56
Total Expenses 63.12 83.63 -24.52
Operating Profit 14.54 11.73 23.96
Net Profit 8.67 6.7 29.4
Equity Capital 16.31 16.31 -
> More on Lincoln Pharmaceuticals Ltd Financials Results

Lincoln Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Hester Bios 711.00 1.71 605.06
Themis Medicare 585.75 -1.25 528.93
Anuh Pharma 207.00 -0.46 518.74
Lincoln Pharma. 192.85 -0.18 385.70
Gufic BioScience 46.40 1.98 359.14
Medicamen Biotec 268.80 4.11 282.78
Orchid Pharma 29.20 0.69 259.76
> More on Lincoln Pharmaceuticals Ltd Peer Group

Lincoln Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 33.18
Banks/FIs 0.18
FIIs 0.96
Insurance 0.00
Mutual Funds 0.00
Indian Public 46.64
Custodians 0.00
Other 19.04
> More on Lincoln Pharmaceuticals Ltd Share Holding Pattern

Lincoln Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -1.03% -0.97% 0.00% 0.02%
1 Month -9.40% -9.10% -3.39% -3.62%
3 Month -20.98% -21.19% -7.65% -7.73%
6 Month 33.00% 33.39% -1.84% -1.12%
1 Year -0.64% NA 2.77% 4.46%
3 Year 534.38% NA 25.72% 30.25%

Lincoln Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 190.10
195.35
Week Low/High 188.85
200.00
Month Low/High 174.20
234.00
YEAR Low/High 128.00
305.00
All TIME Low/High 8.05
305.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard